Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.69
-0.01 (-1.43%)
At close: Sep 26, 2025, 10:33 AM
-1.43% (1D)
| Bid | 0.69 |
| Market Cap | 7.16M |
| Revenue (ttm) | 849K |
| Net Income (ttm) | -11.45M |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -0.75 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.71 |
| Volume | 1,403 |
| Avg. Volume (20D) | 185,931 |
| Open | 0.70 |
| Previous Close | 0.70 |
| Day's Range | 0.69 - 0.71 |
| 52-Week Range | 0.52 - 3.75 |
| Beta | 0.14 |
| Ex-Dividend Date | n/a |
About BCLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCLI
Website n/a
2 months ago
-28.21%
BrainStorm Cell Therapeutics is trading lower afte...
Unlock content with
Pro Subscription
2 months ago
-2.5%
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.
1 month ago · seekingalpha.com
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call TranscriptBrainstorm Cell Therapeutics Inc. (OTC:BCLI) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Alla Patlis - Interim CFO & Controller Chaim Lebovits - President & CEO Ib...